...
首页> 外文期刊>Bioorganic and medicinal chemistry >Tubulin-binding dibenz[c,e]oxepines: Part 2.(1) Structural variation and biological evaluation as tumour vasculature disrupting agents
【24h】

Tubulin-binding dibenz[c,e]oxepines: Part 2.(1) Structural variation and biological evaluation as tumour vasculature disrupting agents

机译:管蛋白结合二苯深[C,E]氧气肟:第2.(1)结构变异和生物学评估作为肿瘤脉管系统破坏剂

获取原文
获取原文并翻译 | 示例

摘要

5,7-Dihydro-3,9,10,11-tetramethoxybenz[c,e]oxepin-4-ol 1, prepared from a dibenzyl ether precursor via Pd-catalysed intramolecular direct arylation, possesses broad-spectrum in vitro cytotoxicity towards various tumour cell lines, and induces vascular shutdown, necrosis and growth delay in tumour xenografts in mice at sub-toxic doses. The biological properties of 1 and related compounds can be attributed to their ability to inhibit microtubule assembly at the micromolar level, by binding reversibly to the same site of the tubulin alpha beta-heterodimer as colchicine 2 and the allocolchinol, N-acetylcolchinol 4. (C) 2017 Elsevier Ltd. All rights reserved.
机译:通过PD催化的分子内直接芳基制备由二苄醚前体制制备的5,7-二氢-3,9,11-10,11-四乙氧基苯深[C,E]氧脂-4-醇1具有朝向各种偏广的体外细胞毒性的广谱 肿瘤细胞系,并在副毒性剂量下诱导肿瘤异种移植物中的血管关断,坏死和生长延迟。 1和相关化合物的生物学特性可归因于它们在微摩尔水平上抑制微管组件的能力,通过可逆地结合到微小蛋白β-异二聚体作为血清晶氨酸2和Allocolchinol,N-乙酰氨基酚4.( c)2017年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号